Scott Matusow
View Scott Matusow's Articles BY TICKER:
ACAD,
ACOR,
ACRX,
ACUR,
AGEN,
ALIM,
ANAC,
ANIK,
ARIA,
ARNA,
ARQL,
ATHX,
ATRS,
AVEO,
BDSI,
BLRX,
CBLI,
CDXS,
CHTP,
CPRX,
CYCC,
EDAP,
ENZN,
ETRM,
FOLD,
GSK,
GTXI,
IBIO,
IMUC,
INSM,
ISR,
MAPP,
MCP,
MDGN,
MEIP,
MELA,
MNKD,
MNOV,
NBY,
NEPT,
NSPH,
OMPI,
OPTR,
OPXA,
PATH,
PFE,
PGNX,
PIP,
POZN,
PSDV,
PSTI,
QCOR,
SCMP,
SDRL,
SGYP,
SIGA,
SNSS,
SNTA,
SPPI,
STSI,
THLD,
TRGT,
TSRX,
VNDA,
VRNG,
VRTX,
WBMD,
ZGNX
- 2 BioPharma Catalyst Trades And 1 Strong Acquisition Target Rumored To Be In Play
- Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Propel Insmed
- Near-Term Catalysts And High Insider Ownership Make GTx An Attractive Buy
- Agenus: Near-Term Drivers With A Market Opportunity Over $17 Billion
- Quickly Approaching Biopharma Catalyst Events
- Cleveland BioLabs Offers Medical Countermeasures Against Potential Terrorist Attacks
- Thursday's BioPharma Trade Movers
- AVEO Poised To Move Higher Before FDA Adcomm Catalyst, Obamacare And Platform Potential
- 3 Small Cap Biopharmas Primed To Move Much Higher Now
- Opexa: A Significant Growth Opportunity For Short-Term Traders And Long-Term Investors
- Obagi Medical Products Acquired Wednesday, These Biotechs May Be Next
- AcelRx Pharmaceutical's Potential Billion-Dollar Treatment Under The Radar
- Trius Therapeutics: New MRSA Treatment Could Bring Billions In Revenues
- Cyclacel Pharma: Undervalued With Its Potential Blockbuster Drug
- Upcoming Catalysts For These BioPharmas Provide Potential Upside
-
Upcoming NDA, Potential Partner Add Further Investment Value For Pozen
- 4 Small Cap Biopharmas With Near-Term Catalysts
- 3 Biopharma Catalyst Trades To Consider For Today
- The Obesity Epidemic: EnteroMedics' New Treatment Approach
- Biopharma Catalyst Trades To Watch For This Week
- Athersys: Upcoming Short-Term Catalyst With Promising Longer Term Potential
- BioLineRx: Upcoming Catalyst With Potential Multi Billion-Dollar Schizophrenia Drug
- Legendary Investor Icahn Still Slugging Away With Enzon Pharma
- Tuesday's Small Cap Biopharma Investment And Catalyst Trade List
- EDAP: An Undervalued Company With An Alternative Treatment For Prostate Cancer
- Thursday's Small Cap Biotech Catalyst Watch List
- ArQule: A Strong Speculation BioPharma Poised For A Quick Move Up On Near Term Catalyst
- Strong Small Cap Biopharma Catalyst Trades And Investments For Consideration
- Synta Pharma: Poised For A Breakout With 4 Near-Term Catalysts
- Mid-Week Biopharma Catalyst Trades To Consider
- Recent Developments Plus Short Interest Could Push Star Scientific's Rally Even Higher
- Tuesday's Small-Cap Biopharma Catalyst Trade List